Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381642 | 12538164 | 2 | F | 20160803 | 20160707 | 20160810 | PER | US-009507513-1606USA014011 | MERCK | 0.00 | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381642 | 12538164 | 1 | PS | ZOCOR | SIMVASTATIN | 1 | Oral | U | 19766 | TABLET | |||||||||
| 125381642 | 12538164 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 125381642 | 12538164 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, QD | U | 0 | 80 | MG | QD | ||||||
| 125381642 | 12538164 | 4 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125381642 | 12538164 | 1 | Hypercholesterolaemia |
| 125381642 | 12538164 | 3 | Hypercholesterolaemia |
| 125381642 | 12538164 | 4 | Hypercholesterolaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125381642 | 12538164 | Blood cholesterol increased | |
| 125381642 | 12538164 | Drug ineffective | |
| 125381642 | 12538164 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |